Annual SG&A
$12.23 M
+$2.60 M+27.06%
31 December 2023
Summary:
Evoke Pharma annual selling, general & administrative expenses is currently $12.23 million, with the most recent change of +$2.60 million (+27.06%) on 31 December 2023. During the last 3 years, it has risen by +$5.80 million (+90.20%). EVOK annual SG&A is now at all-time high.EVOK Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$3.82 M
+$90.70 K+2.43%
30 September 2024
Summary:
Evoke Pharma quarterly selling, general & administrative expenses is currently $3.82 million, with the most recent change of +$90.70 thousand (+2.43%) on 30 September 2024. Over the past year, it has increased by +$692.70 thousand (+22.12%). EVOK quarterly SG&A is now at all-time high.EVOK Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$502.34 M
-$6.15 M-1.24%
30 September 2024
Summary:
Evoke Pharma TTM selling, general & administrative expenses is currently -$502.34 million, with the most recent change of -$6.15 million (-1.24%) on 30 September 2024. Over the past year, it has dropped by -$513.38 million (-4652.57%). EVOK TTM SG&A is now -2430.06% below its all-time high of $14.18 million, reached on 30 September 2024.EVOK TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EVOK Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +27.1% | +22.1% | -4652.6% |
| 3 y3 years | +90.2% | +45.1% | -5585.8% |
| 5 y5 years | +211.9% | +369.7% | -10000.0% |
EVOK Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +90.2% | at high | +120.3% | -22.6% | at low |
| 5 y | 5 years | at high | +227.1% | at high | +388.6% | -54.0% | at low |
| alltime | all time | at high | +2043.3% | at high | +5167.4% | -2430.1% | at low |
Evoke Pharma Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.82 M(+2.4%) | $14.18 M(+5.1%) |
| June 2024 | - | $3.73 M(+18.9%) | $13.49 M(+7.7%) |
| Mar 2024 | - | $3.14 M(-9.8%) | $12.52 M(+2.4%) |
| Dec 2023 | $12.23 M(+27.1%) | $3.48 M(+11.2%) | $12.23 M(+10.8%) |
| Sept 2023 | - | $3.13 M(+13.2%) | $11.03 M(+4.9%) |
| June 2023 | - | $2.77 M(-2.9%) | $10.52 M(+4.5%) |
| Mar 2023 | - | $2.85 M(+24.4%) | $10.07 M(+4.6%) |
| Dec 2022 | $9.62 M(+8.7%) | $2.29 M(-12.5%) | $9.62 M(+6.1%) |
| Sept 2022 | - | $2.61 M(+12.9%) | $9.07 M(-0.2%) |
| June 2022 | - | $2.32 M(-3.7%) | $9.09 M(+1.9%) |
| Mar 2022 | - | $2.41 M(+38.6%) | $8.92 M(+0.8%) |
| Dec 2021 | $8.85 M(+37.7%) | $1.74 M(-34.1%) | $8.85 M(-3.3%) |
| Sept 2021 | - | $2.64 M(+23.0%) | $9.16 M(+9.1%) |
| June 2021 | - | $2.14 M(-8.4%) | $8.40 M(+12.9%) |
| Mar 2021 | - | $2.34 M(+14.5%) | $7.44 M(+15.7%) |
| Dec 2020 | $6.43 M(+72.0%) | $2.04 M(+8.9%) | $6.43 M(+24.4%) |
| Sept 2020 | - | $1.87 M(+58.5%) | $5.17 M(+25.8%) |
| June 2020 | - | $1.18 M(-11.0%) | $4.11 M(+6.9%) |
| Mar 2020 | - | $1.33 M(+69.9%) | $3.84 M(+2.9%) |
| Dec 2019 | $3.74 M(-4.6%) | $782.60 K(-3.9%) | $3.74 M(-7.2%) |
| Sept 2019 | - | $814.20 K(-11.3%) | $4.03 M(-2.0%) |
| June 2019 | - | $918.10 K(-24.9%) | $4.11 M(+0.0%) |
| Mar 2019 | - | $1.22 M(+14.0%) | $4.11 M(+4.9%) |
| Dec 2018 | $3.92 M | $1.07 M(+19.6%) | $3.92 M(+1.2%) |
| Sept 2018 | - | $897.10 K(-2.2%) | $3.87 M(-2.2%) |
| June 2018 | - | $917.30 K(-11.1%) | $3.96 M(+1.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $1.03 M(+0.4%) | $3.92 M(-4.3%) |
| Dec 2017 | $4.09 M(+13.9%) | $1.03 M(+4.4%) | $4.09 M(+5.3%) |
| Sept 2017 | - | $984.00 K(+12.8%) | $3.89 M(+4.1%) |
| June 2017 | - | $872.00 K(-27.9%) | $3.73 M(+1.9%) |
| Mar 2017 | - | $1.21 M(+47.1%) | $3.66 M(+2.0%) |
| Dec 2016 | $3.59 M(-1.9%) | $822.30 K(-0.9%) | $3.59 M(-0.6%) |
| Sept 2016 | - | $830.10 K(+3.4%) | $3.61 M(+0.3%) |
| June 2016 | - | $802.70 K(-29.5%) | $3.60 M(-4.6%) |
| Mar 2016 | - | $1.14 M(+35.0%) | $3.78 M(+3.1%) |
| Dec 2015 | $3.66 M(+16.0%) | $842.80 K(+2.8%) | $3.66 M(+2.9%) |
| Sept 2015 | - | $819.70 K(-16.0%) | $3.56 M(+2.5%) |
| June 2015 | - | $976.40 K(-4.8%) | $3.47 M(+11.5%) |
| Mar 2015 | - | $1.03 M(+38.9%) | $3.11 M(-1.4%) |
| Dec 2014 | $3.16 M(+92.0%) | $738.00 K(+0.7%) | $3.16 M(-6.1%) |
| Sept 2014 | - | $732.80 K(+18.8%) | $3.36 M(+10.7%) |
| June 2014 | - | $616.90 K(-42.4%) | $3.04 M(+21.8%) |
| Mar 2014 | - | $1.07 M(+13.4%) | $2.49 M(+51.6%) |
| Dec 2013 | $1.64 M(+96.6%) | $944.40 K(+132.1%) | $1.64 M(+57.5%) |
| Sept 2013 | - | $406.90 K(+460.5%) | $1.04 M(+34.2%) |
| June 2013 | - | $72.60 K(-67.1%) | $777.90 K(-8.8%) |
| Mar 2013 | - | $221.00 K(-35.7%) | $852.60 K(+1.9%) |
| Dec 2012 | $836.80 K(+46.7%) | $343.60 K(+144.2%) | $836.70 K(+69.7%) |
| Sept 2012 | - | $140.70 K(-4.5%) | $493.10 K(+39.9%) |
| June 2012 | - | $147.30 K(-28.2%) | $352.40 K(+71.8%) |
| Mar 2012 | - | $205.10 K | $205.10 K |
| Dec 2011 | $570.50 K | - | - |
FAQ
- What is Evoke Pharma annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Evoke Pharma?
- What is Evoke Pharma annual SG&A year-on-year change?
- What is Evoke Pharma quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Evoke Pharma?
- What is Evoke Pharma quarterly SG&A year-on-year change?
- What is Evoke Pharma TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Evoke Pharma?
- What is Evoke Pharma TTM SG&A year-on-year change?
What is Evoke Pharma annual selling, general & administrative expenses?
The current annual SG&A of EVOK is $12.23 M
What is the all time high annual SG&A for Evoke Pharma?
Evoke Pharma all-time high annual selling, general & administrative expenses is $12.23 M
What is Evoke Pharma annual SG&A year-on-year change?
Over the past year, EVOK annual selling, general & administrative expenses has changed by +$2.60 M (+27.06%)
What is Evoke Pharma quarterly selling, general & administrative expenses?
The current quarterly SG&A of EVOK is $3.82 M
What is the all time high quarterly SG&A for Evoke Pharma?
Evoke Pharma all-time high quarterly selling, general & administrative expenses is $3.82 M
What is Evoke Pharma quarterly SG&A year-on-year change?
Over the past year, EVOK quarterly selling, general & administrative expenses has changed by +$692.70 K (+22.12%)
What is Evoke Pharma TTM selling, general & administrative expenses?
The current TTM SG&A of EVOK is -$502.34 M
What is the all time high TTM SG&A for Evoke Pharma?
Evoke Pharma all-time high TTM selling, general & administrative expenses is $14.18 M
What is Evoke Pharma TTM SG&A year-on-year change?
Over the past year, EVOK TTM selling, general & administrative expenses has changed by -$513.38 M (-4652.57%)